Expression of human c-raf-1 oncogene proteins in E. coli

Area of Science:

• Molecular Biology
• Protein Biochemistry

Background:

• The c-raf-1 proto-oncogene encodes a serine/threonine kinase involved in cellular signaling pathways.
• Understanding the structure-function relationship of c-raf-1 protein variants is crucial for deciphering its role in cell proliferation and transformation.

Purpose of the Study:

• To express full-length and truncated human c-raf-1 proteins in a prokaryotic system.
• To characterize the expressed c-raf proteins, particularly N-terminal variants, and assess the integrity of their kinase domains.

Main Methods:

• Cloning of human c-raf-1 cDNA (full-length and truncated) into the inducible E. coli expression vector pJL6.
• Induction of protein expression in E. coli.
• Purification of expressed c-raf proteins via immunoprecipitation using raf-specific antisera.

Main Results:

• Successful production of 73 kD (full-length), 57 kD, and 39 kD c-raf proteins in E. coli upon induction.
• Characterization of the p73 variant, showing N-terminal modification with 16 vector-encoded amino acids.
• Demonstration that p57 and p39 variants, representing N-terminal deletions, retain the intact transforming protein kinase domain.
• Efficient purification of these recombinant c-raf proteins from E. coli lysates.

Conclusions:

• The E. coli expression system is suitable for producing functional human c-raf-1 protein variants.
• N-terminal truncations of c-raf-1, such as p57 and p39, preserve the essential protein kinase domain, suggesting their potential roles in signaling.
• Recombinant c-raf proteins can be effectively purified using immunoprecipitation, facilitating further biochemical and functional studies.